Top compounds associated with response to CEP170B


Feature Type Standardized
Nominal ANOVA
mRNA FK866 GDSC1000 pan-cancer AAC -0.19 4e-08
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 1e-07
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 1e-06
mRNA KX2-391 CTRPv2 pan-cancer AAC -0.19 3e-06
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.21 3e-06
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 3e-06
mRNA GSK461364 CTRPv2 pan-cancer AAC -0.18 9e-06
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 2e-05
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 2e-05
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 3e-05
Download CSV